BuzzSparks.org

Hatteras Venture Partners


Bio-pharm. focused Venture Capital

Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an...

Founded in 2000
Homepage:

27701 280 S. Mangum St., Suite 350

Durham
Durham
USA NC

Phone: 1-919-484-0730

Updated on Nov 24, 2013
Hatteras Venture Partners at CrunchBase
Clay B. Thorp General Partner & Co-Founder
Robert A. Ingram General Partner
Douglas Reed General Partner
Christy L. Shaffer Venture Partner
Robert Morff Venture Partner
Dana Fowlkes Venture Partner
Jeff Terrell Analyst
Kenneth B. Lee General Partner
John Crumpler General Partner & Co-Founder
Myla Lai-Goldman Venture Partner
Fred Goldwater Venture Partner
Michael Dial Associate
Past

October, 2013

Hatteras Venture Partners invested $32M in Sideris Pharmaceuticals as a Series A round

Hatteras Venture Partners invested $12.5M in G1 Therapeutics as a Series A round

July, 2012

Hatteras Venture Partners invested $12M in Coferon as a Series B round

June, 2012

Hatteras Venture Partners invested $23M in PhaseBio Pharmaceuticals as a Series B round

January, 2012

Hatteras Venture Partners invested unknown amount in GeneCentric Diagnostics as seed round

Hatteras Venture Partners invested $4M in Clearside Biomedical as unattributed round

September, 2011

Hatteras Venture Partners invested $15M in Clinipace WorldWide as a Series C round

August, 2010

Hatteras Venture Partners invested $32M in TetraLogic Pharmaceuticals as a Series C round

January, 2010

Hatteras Venture Partners invested $25M in PhaseBio Pharmaceuticals as a Series B round

July, 2009

Hatteras Venture Partners invested $25M in Viamet Pharmaceuticals as a Series B round

June, 2008

Hatteras Venture Partners invested $2.6M in ArtusLabs as a Series A round

Hatteras Venture Partners invested $8.8M in SpineAlign Medical as unattributed round

October, 2007

Hatteras Venture Partners invested $6.6M in PhaseBio Pharmaceuticals as a Series B round

June, 2007

Hatteras Venture Partners invested $4M in Viamet Pharmaceuticals as a Series A round

2000

Hatteras Venture Partners was founded in 2000